IGF-1 DES (DES)

Truncated IGF-1 missing first 3 amino acids. More potent than regular IGF-1 due to reduced binding protein affinity.

Key Data

Research Status

Research chemical

Half-Life

20-30 minutes

Administration

Intramuscular (site-specific)

Typical Dosage

50-150 mcg (site-specific)

Mechanism of Action

Binds IGF-1 receptor with greatly reduced binding protein affinity for enhanced bioactivity.

Reported Benefits

• Enhanced anabolic effects
• Localized muscle growth
• Potent fat loss

All information is presented for Research Use Only (RUO). Not medical advice.